The secondary outcome measures will be the scores of Mini-Mental State Examination (MMSE), Unified Parkinson’s Disease Rating Scale Motor Examination (UPDRSIII) and the level of neurofilament light polypeptide (NfL) and glial cell-derived neurotrophic factor (GDNF). Here, GDNF is linked to Parkinson disease.